As of November 2024, REGENXBIO has a market cap of $558.70M. This makes REGENXBIO the world's 10775th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $776.90M | -1.62% |
2023 | $789.66M | -20.86% |
2022 | $997.74M | -30.64% |
2021 | $1.44B | -27.91% |
2020 | $2.00B | 10.72% |
2019 | $1.80B | -2.34% |
2018 | $1.85B | 26.17% |
2017 | $1.46B | 79.25% |
2016 | $816.05M | 11.75% |
2015 | $730.27M | - |